谷歌浏览器插件

订阅小程序

在清言上使用

立即登录

学术主页个人账号

我的关注论文收藏浏览历史

Optimal Treatment Strategy with Nilotinib for Patients with Newly Diagnosed Chronic‐phase Chronic Myeloid Leukemia Based on Early Achievement of Deep Molecular Response (MR4.5): the Phase 2, Multicenter N‐Road Study

Kaichi Nishiwaki,Kei-ji Sugimoto,Shigehisa Tamaki,Junichi Hisatake,Hisayuki Yokoyama,Tadahiko Igarashi,Atsushi Shinagawa,Takeaki Sugawara,Satoru Hara,Kazuhisa Fujikawa,Seiichi Shimizu,Toshiaki Yujiri,Arinobu Tojo,Hisashi Wakita

Cancer medicine（2020）

引用 3|浏览64

暂无评分

关键词

chronic myeloid leukemia,early deep molecular response,nilotinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要